137 related articles for article (PubMed ID: 24532469)
21. POU5F1/Oct-4 expression in breast cancer tissue is significantly associated with non-sentinel lymph node metastasis.
Cai S; Geng S; Jin F; Liu J; Qu C; Chen B
BMC Cancer; 2016 Mar; 16():175. PubMed ID: 26931354
[TBL] [Abstract][Full Text] [Related]
22. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
[No Abstract] [Full Text] [Related]
23. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
[TBL] [Abstract][Full Text] [Related]
24. FLNA is a predictor of chemoresistance and poor survival in cervical cancer.
Jin YZ; Pei CZ; Wen LY
Biomark Med; 2016 Jul; 10(7):711-9. PubMed ID: 27347840
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy.
Niibe Y; Nakano T; Ohno T; Suzuki Y; Oka K; Tsujii H
Int J Gynecol Cancer; 2003; 13(6):849-55. PubMed ID: 14675323
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of prognostic significance in extracapsular spread of pelvic lymph node metastasis in patients with cervical cancer.
Metindir J; Bilir Dilek G
Eur J Gynaecol Oncol; 2008; 29(5):476-8. PubMed ID: 19051816
[TBL] [Abstract][Full Text] [Related]
27. TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
Ye H; Guo X
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31332036
[TBL] [Abstract][Full Text] [Related]
28. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
[TBL] [Abstract][Full Text] [Related]
29. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer.
Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
Arch Gynecol Obstet; 2014 Oct; 290(4):717-23. PubMed ID: 24748337
[TBL] [Abstract][Full Text] [Related]
31. High expression of ezrin predicts poor prognosis in uterine cervical cancer.
Kong J; Li Y; Liu S; Jin H; Shang Y; Quan C; Li Y; Lin Z
BMC Cancer; 2013 Nov; 13():520. PubMed ID: 24182314
[TBL] [Abstract][Full Text] [Related]
32. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
34. Incorporation of the number of positive lymph nodes leads to better prognostic discrimination of node-positive early stage cervical cancer.
Zhou J; Wu SG; Sun JY; Liao XL; Li FY; Lin HX; Yang LC; He ZY
Oncotarget; 2017 Apr; 8(16):26057-26065. PubMed ID: 28199962
[TBL] [Abstract][Full Text] [Related]
35. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
36. [Prognosis of patients with stage Ib-IIb node-positive cervical carcinoma].
Cheng X; Cai SM; Li ZT; Tang MQ; Xue MQ; Zang RY
Ai Zheng; 2003 Nov; 22(11):1219-23. PubMed ID: 14613657
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of miR-15b is associated with clinicopathological features and poor prognosis in cervical carcinoma.
Wen F; Xu JZ; Wang XR
Arch Gynecol Obstet; 2017 Mar; 295(3):743-749. PubMed ID: 28091743
[TBL] [Abstract][Full Text] [Related]
38. Cancer Stem Cells, CD44, and Outcomes Following Chemoradiation in Locally Advanced Cervical Cancer: Results From a Prospective Study.
Chopra S; Deodhar K; Pai V; Pant S; Rathod N; Goda JS; Sudhalkar N; Pandey P; Waghmare S; Engineer R; Mahantshetty U; Ghosh J; Gupta S; Shrivastava S
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):161-168. PubMed ID: 30213750
[TBL] [Abstract][Full Text] [Related]
39. Expression of IL-1α and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer.
Song Z; Lin Y; Ye X; Feng C; Lu Y; Yang G; Dong C
Med Sci Monit; 2016 Nov; 22():4475-4481. PubMed ID: 27866212
[TBL] [Abstract][Full Text] [Related]
40. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
Qin R; Cao L; Wang J; Liu J
Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
